Table 2. Safety and procedural aspects of CrossCountryTM Transbronchial Access Tool.
| Site | Total number (%) | Size, cm (mean ± SD, range) | Visibility on fluoroscopy (%) | Adverse events | Tunnel length of 7 lesions accessed by TBAT, cm (mean ± SD, range) |
|---|---|---|---|---|---|
| RUL | 4 (18.2) | 2.38±1.37, 0.7–3.5 | 3 (75.0) | 0 | 1.33±0.29, 1–1.5 |
| LUL | 11 (50.0) | 1.98±0.43, 1.2–2.8 | 4 (46.4) | 0 | 1.55±0.44, 1–2 |
| RLL | 2 (9.1) | 3.25±2.76, 1.3–5.2 | 1 (50.0) | 0 | 1.25±0.35, 1–1.5 |
| LLL | 3 (13.6) | 1.4±0.26, 1.1–1.6 | 2 (66.7) | 0 | 1.75±0.35, 1.5–2.0 |
| RML | 2 (9.1) | 2.05±.5, 1.7–2.4 | 2 (100.0) | 0 | 1.5±0.71, 1–2 |
RUL, right upper lobe; LUL, left upper lobe; RLL, right lower lobe; LLL, left lower lobe; RML, right middle lobe; TBAT, Transbronchial Access Tool.